Stock Details
BSX is Boston Scientific Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 40.35$. Average daily volumn in 3 months 8.88M. Market cap 54.35B



Stock symbol : BSX. Exchange : NYSE. Currency : USD
Lastest price : 38.02$. Total volume : 10.45M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Boston Scientific Corporation (BSX)
Last Price
38.02$
Change
1.08
Volume
10.45M

Previous Close36.94
Open37.20
Day Range36.99-38.14
Bid37.51 x 3.2k
Ask37.95 x 800
Volume10.45M
Average Volume8.88M
Market Cap54.35B
Beta0.82
52 Week Range34.98-47.50
Trailing P/E71.74
Foward P/E18.92
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to Boston Scientific Corporation's financial reports the company's revenue in 2021 were 11.89B an decrease( +22.22%) over the years 2020 revenue that were of 9.91B. In 2021 the company's total earnings were 1.04B while total earnings in 2020 were -82M(-1319.51%).


Loading ...



Organization

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable c... ardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Market Cap:
54.35B
Revenue:
11.89B
Total Assets:
32.23B
Total Cash:
1.93B



News about "Boston Scientific Corporation"

boston-scientific-nysebsx-price-target-lowered-to-4500-at-btig-research-image

Boston Scientific (NYSE:BSX) Price Target Lowered to $45.00 at BTIG Research

Source from : Defense World - 12 hours ago

Boston Scientific (NYSE:BSX โ€“ Get Rating) had its price objective lowered by BTIG Research from $52.00 to $45.00 in a research report report published on Friday morning, The Fly reports. The brokerage ...See details»


caprock-group-inc-grows-stake-in-boston-scientific-co-nysebsx-image

CAPROCK Group Inc. Grows Stake in Boston Scientific Co. (NYSE:BSX)

Source from : Defense World - 1 days ago

CAPROCK Group Inc. grew its position in shares of Boston Scientific Co. (NYSE:BSX โ€“ Get Rating) by 42.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange ...See details»


boston-scientific-to-buy-korean-medtech-manufacturer-for-230m-image

Boston Scientific to buy Korean medtech manufacturer for $230M

Source from : The Business Journals - 9 days ago

Boston Scientific Corporation is shelling out $230 million in U.S. dollars to buy a Korean manufacturer called M.I.Tech Co., Ltd. The Marlborough medical device maker (NYSE: BSX) will own a majority ...See details»


boston-scientific-to-purchase-majority-stake-of-mitech-image

Boston Scientific To Purchase Majority Stake of M.I.Tech

Source from : medtechintelligence - 3 days ago

M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.โ€ ...See details»


boston-scientific-remembers-cofounder-pete-nicholas-1941-2022-image

Boston Scientific Remembers Cofounder Pete Nicholas, 1941-2022

Source from : Endovascular Today - 5 days ago

In an extensive online tribute, Boston Scientific Corporation announced the death of Peter M. โ€œPeteโ€ Nicholas, the com ...See details»


boston-scientific-to-purchase-synergy-innovation-cos-64-stake-in-mitech-image

Boston Scientific To Purchase Synergy Innovation Co.'s 64% Stake In M.I.Tech

Source from : Nasdaq - 10 days ago

Boston Scientific Corp. (BSX) has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake of M.I.Tech Co. a publicly traded Korean manufacturer and ...See details»


Boston Scientific to Buy 64% of M.I. Tech for About $230 Million >BSX

Source from : MarketWatch - 10 days ago

Boston Scientific Corp. on Wednesday agreed to buy the roughly 64% stake in Korean medical-device maker M.I. Tech Co. Ltd. held by Synergy Innovation Co. Ltd. for about $230 million, Boston Scientific ...See details»


the-zacks-analyst-blog-highlights-adobe-the-southern-company-northrop-grumman-boston-scientific-marathon-petroleum-and-archer-daniels-midland-image

The Zacks Analyst Blog Highlights Adobe, The Southern Company, Northrop Grumman, Boston Scientific, Marathon Petroleum and Archer-Daniels-Midland

Source from : YAHOO!Finance - 2 days ago

Adobe, The Southern Company, Northrop Grumman, Boston Scientific, Marathon Petroleum and Archer-Daniels-Midland have been included in this Analyst Blog.See details»


boston-scientific-buys-substantial-stake-in-korean-medtech-player-image

Boston Scientific Buys Substantial Stake In Korean MedTech Player

Source from : YAHOO!Finance - 10 days ago

Boston Scientific Corporation (NYSE: BSX) has agreed to purchase Synergy Innovation Co Ltd's majority stake (~64%) of M.I.Tech Co Ltd, a publicly-traded Korean manufacturer, and distributor of medical ...See details»


Boston Scientific (BSX) to Broaden Stent Portfolio With Buyout

Source from : Nasdaq - 9 days ago

Boston Scientific Corporation BSX recently agreed to purchase the majority stake in M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd. This latest investment is aimed at broadening Boston ...See details»


comera-life-sciences-taps-boston-scientific-veteran-for-cfo-role-image

Comera Life Sciences taps Boston Scientific veteran for CFO role

Source from : cfodive - 9 days ago

Boston Scientific alum Michael Campbell will act as CFO for recently public life sciences Comera, taking the helm approximately one month following the companyโ€™s SPAC merger.See details»


Declining Stock and Decent Financials: Is The Market Wrong About Boston Scientific Corporation (NYSE:BSX)?

Source from : Yahoo Finance - 14 days ago

Boston Scientific (NYSE:BSX) has had a rough three months with its share price down 11%. However, stock prices are usually driven by a companyโ€™s financials over the long term, which in this case look ...See details»


Boston Scientific Announces Agreement to Purchase Majority Stake of M.I.Tech Co., Ltd from Synergy Innovation Co., Ltd

Source from : Business Insider - 10 days ago

MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd ...See details»


Boston Scientific Corp - Stock Financials BSX

Source from : Morningstar%2c Inc. - 11 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.See details»